ISBInsight: An emerging trend in innovation is cluster development. This is where universities and start-ups are coming together and working with businesses to invest in ideation as well as execution. What are some benefits and challenges of this approach?
Anand Nandkumar: There are many benefits from this kind of arrangement. Companies are typically searching for the next big idea. But given …Read More »
From virtually being non-existent in 2000, India had the third largest number of start-ups behind only the US and the UK in 2016 (see Figure 1). Most of this activity can be attributed to increased startup activity in the Information, Communication and Technology (ICT) sector (see Figure 2). What is even more impressive is the fact that India ranks third …Read More »
Increasing international trade between nations has coincided with a surge in MNFs conducting their R&D activity overseas in countries such as India and China. Fortune 500 firms have about 100 R&D laboratories in China and about 63 in India. Moreover, according to a survey by The Economist, about 83% of the new R&D centres added by Fortune 1000 firms are …Read More »
Indian firms are relatively well acknowledged for their ability to generate non-technical innovations such as new business models. For instance, the global service delivery model that emerged from India resulted in the advent of the Indian software industry. However, India’s competence in generating technological innovations is relatively unknown. This paper presents an analysis of Indian patent data to better understand …Read More »
Environment impacts performance capabilities of entrepreneurial firms.
BASED ON THE RESEARCH OF ANAND NANDKUMAR (ISB) AND ASHISH ARORA (DUKE UNIVERSITY)
The typical entrepreneur dreams of creating a business that creates wealth; however, he can only do so if he survives to see his idea blossom. Further, the more accomplished he is, the more likely he would like his idea to blossom fast, …Read More »
Professor Anand Nandkumar of ISB, Professor Charles Dhanaraj of Kelley School of Business, along with Mridula Anand, trace Novartis’ prolonged tussle with the Indian patent regime to get its cancer drug, Glivec, patented in India. The case is set against the backdrop of the Intellectual Property Appellate Board declining Novartis’ patent application on the grounds that the cost of the …Read More »
The quest to be recognised as a global leader in innovation led Biocon to discover and develop IN-105, oral insulin for diabetics. Faced with initial success, the Biocon team was rearing to charge ahead with the final testing. Everything looked rosy, but was it actually so? Nita Sachan, Senior Researcher, Biocon Cell for Innovation Management at the Centre for Leadership, …Read More »
This article examines the impact of the trade-related aspects of intellectual property rights (Trips) agreement on innovation in India.
In 1994, India signed the Trips agreement mandated by the World Trade Organisation (WTO). The agreement, which came into effect on January 1, 1995, is the most important multilateral agreement on intellectual property (IP). By enforcing a minimum standard of IP rights …Read More »